相似文献
1
The obesity epidemic as harbinger of a metabolic disorder epidemic: trends in overweight, hypercholesterolemia, and diabetes treatment in Geneva, Switzerland, 1993-2003.
Am J Public Health. 2005 Apr;95(4):632-5. doi: 10.2105/2004.047877.
2
Anthropometry measures and prevalence of obesity in the urban adult population of Cameroon: an update from the Cameroon Burden of Diabetes Baseline Survey.
BMC Public Health. 2006 Sep 13;6:228. doi: 10.1186/1471-2458-6-228.
3
Under-estimation of obesity, hypertension and high cholesterol by self-reported data: comparison of self-reported information and objective measures from health examination surveys.
Eur J Public Health. 2014 Dec;24(6):941-8. doi: 10.1093/eurpub/cku074. Epub 2014 Jun 6.
4
Heterogeneity of body mass index, waist circumference, and waist-to-hip ratio in predicting obesity-related metabolic disorders for Taiwanese aged 35-64 y.
Clin Nutr. 2009 Oct;28(5):543-8. doi: 10.1016/j.clnu.2009.04.017. Epub 2009 May 27.
5
Cardiovascular risk factors attributable to obesity and overweight in Switzerland.
Nutr Metab Cardiovasc Dis. 2012 Nov;22(11):952-8. doi: 10.1016/j.numecd.2011.01.004. Epub 2011 Apr 8.
6
Trends in risk factors for the major "lifestyle-related diseases" in Geneva, Switzerland, 1993-2000.
Ann Epidemiol. 2003 Aug;13(7):537-40. doi: 10.1016/s1047-2797(03)00055-3.
7
Converging prevalences of obesity across educational groups in Switzerland.
Obesity (Silver Spring). 2006 Nov;14(11):2080-8. doi: 10.1038/oby.2006.243.
8
Prevalence and impact of cardiovascular risk factors in Bucaramanga, Colombia: results from the Countrywide Integrated Noncommunicable Disease Intervention Programme (CINDI/CARMEN) baseline survey.
Eur J Cardiovasc Prev Rehabil. 2006 Oct;13(5):769-75. doi: 10.1097/01.hjr.0000219113.40662.dd.
9
Obesity is major determinant of coronary risk factors in India: Jaipur Heart Watch studies.
Indian Heart J. 2008 Jan-Feb;60(1):26-33.
10
[Lipid distribution in the adult population of Catalonia].
Rev Clin Esp. 1993 Jun;193(1):35-42.
引用本文的文献
1
Thirteen-year trends in the prevalence of diabetes according to socioeconomic condition and cardiovascular risk factors in a Swiss population.
BMJ Open Diabetes Res Care. 2020 Jul;8(1). doi: 10.1136/bmjdrc-2020-001273.
2
Age, period and cohort analysis of high cholesterol levels in Iranian adults over a 20-year period.
J Diabetes Metab Disord. 2019 Jun 25;18(2):289-299. doi: 10.1007/s40200-019-00410-5. eCollection 2019 Dec.
3
Effect of acute mid-intensity treadmill exercise on the androgen hormone level and uncoupling protein-1 expression in brown fat tissue of mouse.
J Exerc Nutrition Biochem. 2018 Mar 30;22(1):15-21. doi: 10.20463/jenb.2018.0003.
4
Finding big shots: small-area mapping and spatial modelling of obesity among Swiss male conscripts.
BMC Obes. 2016 Feb 18;3:10. doi: 10.1186/s40608-016-0092-6. eCollection 2016.
5
Multivariable analysis of total cholesterol levels in male Swiss Armed Forces conscripts 2006-2012 (N = 174,872).
BMC Cardiovasc Disord. 2016 Feb 17;16:43. doi: 10.1186/s12872-016-0218-2.
6
Comparison of Age- Standard Incidence Rate Trends of Gynecologic and Breast Cancer in Iran and Other Countries.
Iran J Public Health. 2014 Oct;43(10):1372-9.
7
Prevalence of chronic medical conditions in Switzerland: exploring estimates validity by comparing complementary data sources.
BMC Public Health. 2014 Nov 7;14:1157. doi: 10.1186/1471-2458-14-1157.
8
Socioeconomic, temporal and regional variation in body mass index among 188,537 Swiss male conscripts born between 1986 and 1992.
PLoS One. 2014 May 12;9(5):e96721. doi: 10.1371/journal.pone.0096721. eCollection 2014.
9
Simvastatin inhibits LPS-induced alveolar bone loss during metabolic syndrome.
J Dent Res. 2014 Mar;93(3):294-9. doi: 10.1177/0022034513516980. Epub 2013 Dec 18.
10
Age and gender differences in the social patterning of cardiovascular risk factors in Switzerland: the CoLaus study.
PLoS One. 2012;7(11):e49443. doi: 10.1371/journal.pone.0049443. Epub 2012 Nov 13.
本文引用的文献
1
In a quasi-simultaneous assessment, imprecise cholesterol monitoring and screening tests were improved.
J Clin Epidemiol. 2005 Aug;58(8):841-8. doi: 10.1016/j.jclinepi.2005.01.009.
2
Estimating and approximating prevalence trends.
Soz Praventivmed. 2004;49(3):224-6. doi: 10.1007/s00038-004-3091-1.
3
Does walking 15 minutes per day keep the obesity epidemic away? Simulation of the efficacy of a populationwide campaign.
Am J Public Health. 2004 Mar;94(3):437-40. doi: 10.2105/ajph.94.3.437.
4
The escalating pandemics of obesity and sedentary lifestyle. A call to action for clinicians.
Arch Intern Med. 2004 Feb 9;164(3):249-58. doi: 10.1001/archinte.164.3.249.
5
Trends in risk factors for the major "lifestyle-related diseases" in Geneva, Switzerland, 1993-2000.
Ann Epidemiol. 2003 Aug;13(7):537-40. doi: 10.1016/s1047-2797(03)00055-3.
6
Trends in risk factors for lifestyle-related diseases by socioeconomic position in Geneva, Switzerland, 1993-2000: health inequalities persist.
Am J Public Health. 2003 Aug;93(8):1302-9. doi: 10.2105/ajph.93.8.1302.
7
Obesity and the environment: where do we go from here?
Science. 2003 Feb 7;299(5608):853-5. doi: 10.1126/science.1079857.
8
Prevalence and trends in obesity among US adults, 1999-2000.
JAMA. 2002 Oct 9;288(14):1723-7. doi: 10.1001/jama.288.14.1723.
9
Diabetes trends in the U.S.: 1990-1998.
Diabetes Care. 2000 Sep;23(9):1278-83. doi: 10.2337/diacare.23.9.1278.
10
Obesity and other health determinants across Europe: the EURALIM project.
J Epidemiol Community Health. 2000 Jun;54(6):424-30. doi: 10.1136/jech.54.6.424.
Zotero 插件